KEY POINTS First independent assessment of the global work has been performed to tackle Antimicrobial Resistance (AMR) worldwide. GlaxoSmithKline and …

You have read of your 8 free articles this month.

Subscribe to
Medgenera All-Access

Enjoy unlimited access to all contents, resources, exclusive market research reports, databases, surveys and many more features by subscribing to Medgenera All-Access.

Access articles & resources worth up to US $4, 000 per month.

Register with your email to read the full article.

This article is FREE for you! Unlock the unlimited access by subscribing to Medgenera All-Access.



2018 is the Make or Break Year for Bugworks Research: CEO

Bangalore-based Bugworks Research is the only biotech startup in Asia which received CARB-X funding to combat antibiotic resistance issue by developing new antibiotics candidate. Bugworks' CEO Dr. Anandkumar talked about his concern over the rising superbugs problem and his vision for Bugworks in 2018.


FDA Approves Imfinzi for Not Advanced, Inoperable Lung Cancer

AstraZeneca’s bladder and lung cancer drug, Imfinzi® (durvalumab) received the US FDA approval for the expanded use of the drug ...


3D Bioprinting Biotech Pandorum Raises $3.6 M, Aims to Reach Market

Bangalore-based 3D bioprinting startup, Pandorum Technologies has raised $3.6 million in the Series A funding round led by Indian Angel Network. Pandorum develops 3D printed human tissues for medical research and development. It has developed India’s first 3D-printed artificial human liver tissues in 2015 which mimic human liver tissue at structural and functional level. Continue reading...


Sanofi’s Next-Generation Insulin, Toujeo Launches in India

Sanofi India launched its new product- Toujeo® (insulin glargine injection) in India. It is once-daily, long-acting basal insulin that improves blood sugar control in people with type 1 and types 2 diabetes. Continue reading...

Most Popular


7 New Ideas to Start a Healthcare Business in India (2018)

Healthcare in India is showing a gradual progress and there is an abundance of opportunity to create an evolving business by tackling the major challenges of the mass population. Herein, we are proposing the seven new healthcare business ideas in India in 2018 which are based on our observations of the current Indian market, its behavior, challenges, and opportunities.


9 Most Valuable Drugs Under Development (2018)

The top 9 drugs currently under research and developments are ranked based on their Net Present Value. These drugs are forecasted to be the future blockbuster. With $10,199 million Net Present Value, Aducanumab, the Ant-Alzheimer's investigational drug of Biogen is ranked as the topmost valued upcoming drug under development. Total Word Counts of the article: 782. Continue reading..

Leave a reply